ScripMerck & Co’s PD-1 inhibitor for multiple cancer indications Keytruda (pembrolizumab) comfortably retained its number one spot as the drug generating the highest global revenues in the first quarte
ScripLaunched just two years ago, Spyre Therapeutics wants to surpass the biggest players in the anti-inflammatory field, aiming to beat Roche in the TL1A area and ‘stand on the shoulders’ of Johnson &
ScripPresident Donald Trump is repeating his threats of tariffs on the pharmaceutical industry and pressurizing companies to bring more manufacturing back to the US and while Ireland would be, on paper
ScripRiding high on the wave of its dual GIP/GLP-1 agonist, tirzepatide, Eli Lilly awarded its CEO the highest total remuneration package of the top 12 big pharma companies in 2024. David Ricks’s total com